HemaSphere (Aug 2023)
PB2411: THE EFFICACY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR AUTOLOGOUS-HSCT IN LOW-RISK AND INTERMEDIATE-RISK AML PATIENTS
- Weihua Zhai,
- Shulian Chen,
- Xiaoyu Zhang,
- Yi He,
- Sizhou Feng,
- Mingzhe Han,
- Xingli Zhao,
- Jie Bai,
- Lijuan LI,
- Zhihua Zhang,
- Ying Wang,
- Erlie Jiang,
- Jianxiang Wang
Affiliations
- Weihua Zhai
- 1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China
- Shulian Chen
- 1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China
- Xiaoyu Zhang
- 1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China
- Yi He
- 1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China
- Sizhou Feng
- 1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China
- Mingzhe Han
- 1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China
- Xingli Zhao
- 2 Tianjin People’s Hospital, School of Medicine, Nankai University, Oncology and Hematology, Tianjin, China
- Jie Bai
- 3 The Second Hospital of Tianjin Medical University, Hematology, Tianjin, China
- Lijuan LI
- 4 Tianjin Medical University General Hospital, Hematology, Tianjin, China
- Zhihua Zhang
- 5 The Affiliated Hospital of Chengde Medical College, Hematology, Chengde, China
- Ying Wang
- 1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China
- Erlie Jiang
- 1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China
- Jianxiang Wang
- 1 Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Hematology, Tianjin, China
- DOI
- https://doi.org/10.1097/01.HS9.0000976352.90020.24
- Journal volume & issue
-
Vol. 7
p. e9002024
Abstract
No abstracts available.